![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. 4'-chloro-n-(1-isopropyl-4-piperidyl)-2-phenylacetanilide
2. Lorcainid
3. Lorcainide
4. Lorcainide Monohydrochloride
5. R 15889
6. R15889
7. Ro 13-1042
1. Lopantrol
2. Socainide Hydrochloride
3. Isocainide Hydrochloride
4. Lorcainide Hydrochloride [usan]
5. Einecs 261-504-6
6. N-(4-chlorophenyl)-2-phenyl-n-(1-propan-2-ylpiperidin-1-ium-4-yl)acetamide;chloride
7. Ro 13-1042
8. Lorivox
9. R 15889
10. 1t1s98onm1
11. 1313498-17-7
12. Benzeneacetamide, N-(4-chlorophenyl)-n-(1-(1-methylethyl)-4-piperidinyl)-, Monohydrochloride
13. Lorcainida Clorhidrato [spanish]
14. Lorcainida Clorhidrato
15. Unii-1t1s98onm1
16. N-(p-chlorophenyl)-n-(1-isopropylpiperidin-4-yl)phenylacetamide Hydrochloride
17. Nsc 310411
Molecular Weight | 407.4 g/mol |
---|---|
Molecular Formula | C22H28Cl2N2O |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 5 |
Exact Mass | 406.1578689 g/mol |
Monoisotopic Mass | 406.1578689 g/mol |
Topological Polar Surface Area | 24.8 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 433 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)